Tesamorelin is a synthetic analog of growth hormone–releasing hormone (GHRH). It has been extensively studied in clinical and research settings for its activity at GHRH receptors and its role in growth hormone signaling pathways related to metabolic and adipose tissue–associated regulatory mechanisms.